Medical Health Screening Market Report 2025

The medical health screening market size has grown strongly in recent years. It will grow from $18.5 billion in 2024 to $19.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising incidence of chronic diseases, government-driven preventive health campaigns, an aging global population, expanded insurance coverage, and a higher frequency of routine check-ups.

The medical health screening market size is expected to see strong growth in the next few years. It will grow to $25.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the expansion of personalized medicine, increased investment in digital health platforms, the rising prevalence of non-communicable diseases (NCDs), the growing middle class in emerging markets, and heightened health consciousness. Key trends expected during this period include the use of artificial intelligence in diagnostic interpretation, wearable health monitoring devices, telehealth-integrated screening tools, portable and handheld screening devices, AI integration in screening protocols, and blockchain technology for health data security.

The rising prevalence of chronic diseases is expected to drive the growth of the medical health screening market in the coming years. Chronic diseases are long-term health conditions - such as diabetes, heart disease, and asthma - that typically last a year or more and require ongoing medical care or limit daily activities. This increase in chronic diseases is largely due to sedentary lifestyles, where extended inactivity weakens overall health and raises susceptibility to long-term conditions. Medical health screening plays a crucial role in managing chronic diseases by enabling early detection of risk factors and symptoms, which allows for timely intervention and management. This can help prevent complications, improve quality of life, and lessen the overall impact of these diseases. For example, in April 2025, the International Diabetes Federation, a Belgium-based non-profit organization, reported that 589 million adults aged 20-79 are currently living with diabetes worldwide, a number projected to rise to 853 million by 2050. Thus, the growing burden of chronic diseases is fueling the expansion of the medical health screening market.

Key players in the medical health screening market are focusing on introducing cutting-edge solutions such as artificial intelligence (AI)-powered radiology informatics and cancer screening technologies to improve early detection, diagnostic accuracy, and clinical workflow efficiency. AI-powered radiology informatics and cancer screening involve using AI to analyze medical imaging data and detect signs of cancer or other abnormalities more quickly and accurately. For instance, in February 2025, DeepHealth, a US-based health informatics company, launched a new range of AI-driven radiology informatics and cancer screening tools through their cloud-native platform, DeepHealth OS. This suite includes the Diagnostic Suite, a comprehensive AI-based diagnostic workspace, along with advanced AI applications for screening lung, prostate, and brain health. These innovations are designed to boost diagnostic precision, streamline clinical processes, and enhance operational efficiency across various healthcare environments.

In January 2023, PAM Group, a UK-based provider of occupational health, rehabilitation, and absence management services, acquired MedProtect for an undisclosed sum. This acquisition is aimed at strengthening PAM Group’s position in the occupational health and wellbeing sector by integrating MedProtect’s specialized mobile health screening services. The combined entity is now able to offer more cost-effective health solutions to a wider client base while promoting continued growth and innovation within the industry. MedProtect, based in the UK, offers occupational health screening services, including mobile units for hearing tests, biological monitoring, and lung function evaluations.

Major players in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Teladoc Health Inc., Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc., DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc., Freenome Holdings Inc., Genova Diagnostics Inc., Cerba Healthcare SAS, DELFI Diagnostics Inc., Truvian Sciences Inc., ACM Medical Laboratory Inc., LabPlus, and BlueHive Health.

North America was the largest region in the medical health screening market in 2024. The regions covered in medical health screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical health screening market includes revenues earned by entities by providing services such as blood pressure measurement, mental health assessment, infectious disease screening, immunization status review, and lifestyle risk assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The medical health screening market research report is one of a series of new reports that provides medical health screening market statistics, including medical health screening industry global market size, regional shares, competitors with a medical health screening market share, detailed medical health screening market segments, market trends and opportunities, and any further data you may need to thrive in the medical health screening industry. This medical health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical health screening is the systematic process of performing various tests and examinations on seemingly healthy individuals to detect potential health issues or risk factors before symptoms develop. This early detection strategy allows healthcare providers to take timely action, lessen disease severity, and enhance overall health outcomes through preventive care.

The primary categories of tests in medical health screening include routine tests, non-routine tests, cancer screening tests, specialty tests, and others. Routine tests are standard medical examinations conducted regularly to monitor general health and identify potential problems early. These tests involve different sample types, such as blood, urine, saliva, and others, and serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, workplaces, research institutions, and more.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.